Ramishetti Srinivas, Huang Leaf
Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC 27599, USA.
Ther Deliv. 2012 Dec;3(12):1429-45. doi: 10.4155/tde.12.127.
Nanotechnology is rapidly evolving and dramatically changing the paradigms of drug delivery. The small sizes, unique chemical properties, large surface areas, structural diversity and multifunctionality of nanoparticles prove to be greatly advantageous for combating notoriously therapeutically evasive diseases such as cancer. Multifunctional nanoparticles have been designed to enhance tumor uptake through either passive or active targeting, while also avoiding reticuloendothelial system uptake through the incorporation of PEG onto the surface. First-generation nanoparticle systems, such as liposomes, are good carriers for drugs and nucleic acid therapeutics, although they have some limitations. These lipid bilayers are now being utilized as excellent carriers for drug-loaded, solid core particles such as iron oxide, mesoporus silica and calcium phosphate. In this article, their design, as well as their multifunctional role in cancer therapy are discussed.
纳米技术正在迅速发展,并极大地改变着药物递送的模式。纳米颗粒的小尺寸、独特的化学性质、大表面积、结构多样性和多功能性,被证明对于对抗诸如癌症等 notoriously therapeutically evasive(此处疑有误,推测可能是“难治性”之类的意思)疾病具有极大优势。多功能纳米颗粒已被设计用于通过被动或主动靶向增强肿瘤摄取,同时还通过在表面掺入聚乙二醇来避免网状内皮系统摄取。第一代纳米颗粒系统,如脂质体,虽然有一些局限性,但却是药物和核酸治疗的良好载体。这些脂质双层现在正被用作载药实心核颗粒(如氧化铁、介孔二氧化硅和磷酸钙)的优良载体。本文将讨论它们的设计以及在癌症治疗中的多功能作用。